{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02323867",
            "orgStudyIdInfo": {
                "id": "13-010495"
            },
            "secondaryIdInfos": [
                {
                    "id": "BT13BT\u03b851",
                    "type": "OTHER",
                    "domain": "The Children's Hospital of Philadelphia"
                }
            ],
            "organization": {
                "fullName": "Children's Hospital of Philadelphia",
                "class": "OTHER"
            },
            "briefTitle": "Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies",
            "officialTitle": "UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES",
            "acronym": "AB-CliniMACs",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "allogeneic-stem-cell-transplant-with-alpha-beta-t-and-b-cell-depletion-for-hematologic-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2014-10"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2014-10-22",
            "studyFirstSubmitQcDate": "2014-12-23",
            "studyFirstPostDateStruct": {
                "date": "2014-12-24",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-06-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Timothy Olson",
                "investigatorTitle": "Medical Director, Hematopoietic Stem Cell Transplantation (HSCT) Program",
                "investigatorAffiliation": "Children's Hospital of Philadelphia"
            },
            "leadSponsor": {
                "name": "Children's Hospital of Philadelphia",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true
        },
        "descriptionModule": {
            "briefSummary": "This is a single arm pilot study for patients using \u03b1/\u03b2 T cell-depleted peripheral Stem Cell Transplantation (PSCT) in with alternative donor sources with hematologic malignancies receiving alternative donor (unrelated or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS system for T cell depletion plus CD19+ B cell depletion to determine efficacy as determined by engraftment and graft versus host disease (GVHD), and one year leukemia free survival."
        },
        "conditionsModule": {
            "conditions": [
                "Leukemia",
                "Lymphoma",
                "Myelodysplasia"
            ],
            "keywords": [
                "Transplant",
                "Alternative Donor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "intervention with device: Alpha Beta T cell depletion",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Alpha Beta Total Body Irradiation - total body irradiation (TBI) first",
                    "type": "EXPERIMENTAL",
                    "description": "Alpha Beta Total Body Irradiation - TBI first Day Treatment\n\n* 11 Anti-thymocyte globulin (ATG)\n* 10 ATG\n* 9 ATG\n* 8 TBI\n* 7 TBI\n* 6 TBI\n* 5 Thiotepa\n* 4 Thiotepa\n* 3 Cyclophosphamide\n* 2 Cyclophosphamide\n* 1 Rest 0 Transplant with alpha beta T cell depleted stem cells",
                    "interventionNames": [
                        "Device: Alpha Beta T cell depletion"
                    ]
                },
                {
                    "label": "Alpha Beta Total Body Irradiation - TBI last",
                    "type": "EXPERIMENTAL",
                    "description": "Alpha Beta Total Body Irradiation - TBI last Day Treatment\n\n* 9 ATG\n* 8 ATG\n* 7 Thiotepa + ATG\n* 6 Thiotepa\n* 5 Cyclophosphamide\n* 4 Cyclophosphamide\n* 3 TBI\n* 2 TBI\n* 1 TBI 0 Transplant with alpha beta T cell depleted stem cells",
                    "interventionNames": [
                        "Device: Alpha Beta T cell depletion"
                    ]
                },
                {
                    "label": "Alpha Beta Non-irradiation regimen",
                    "type": "EXPERIMENTAL",
                    "description": "Alpha Beta Non-irradiation regimen Day Treatment\n\n* 9 Busulfan + ATG\n* 8 Busulfan + ATG\n* 7 Busulfan +ATG\n* 6 Busulfan\n* 5 Thiotepa\n* 4 Thiotepa\n* 3 Cyclophosphamide\n* 2 Cyclophosphamide\n* 1 0 Transplant with alpha beta T cell depleted stem cells",
                    "interventionNames": [
                        "Device: Alpha Beta T cell depletion"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Alpha Beta T cell depletion",
                    "armGroupLabels": [
                        "Alpha Beta Non-irradiation regimen",
                        "Alpha Beta Total Body Irradiation - TBI last",
                        "Alpha Beta Total Body Irradiation - total body irradiation (TBI) first"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Engraftment: rates of engraftment, defined as the first day of Absolute Neutrophil Count (ANC) greater than 500 for the first of three consecutive days",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Severe acute and chronic graft versus host disease (GVHD)",
                    "description": "Estimation of the incidence and extent of acute and chronic GVHD. The overall incidence of acute GVHD, the incidence of Grade 4 acute GVHD and the incidence of chronic GVHD.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Leukemias/lymphomas\n\n   * Acute myeloid leukemia, primary or secondary Disease status: remission or \\<10% bone marrow blasts\n   * Myelodysplasia\n   * Acute lymphoblastic leukemia Disease status: in hematologic remission\n   * Chronic myelogenous leukemia Disease status: chronic phase, accelerated phase or blast crisis now in second chronic phase.\n   * Mixed lineage or biphenotypic acute leukemia\n   * Lymphoblastic lymphoma Disease status: remission\n   * Burkitt's lymphoma/leukemia: Disease status- in remission\n2. Acceptable organ status clearance\n3. No active untreated infection. Patients with possible fungal infections must have had at least 2 weeks of appropriate anti-fungal antibiotics and be asymptomatic\n4. Signed informed consent.\n5. Negative pregnancy test for females of childbearing potential.\n\nExclusion Criteria:\n\n1. Patients who do not meet disease, organ or infectious criteria.\n2. No suitable donor\n3. Received previous allogeneic transplant\n\nDonor must be either unrelated, mismatched up to one antigen/one antigen and one allele or a related, HLA match other than a sibling.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "23 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Megan Atkinson",
                    "role": "CONTACT",
                    "phone": "215-590-2820",
                    "email": "cttsbmtintake@chop.edu"
                },
                {
                    "name": "Patricia Hankins, BSN, RN, CCRC",
                    "role": "CONTACT",
                    "phone": "215-590-5168",
                    "email": "hankinsp@chop.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Timothy Olson, MD, PhD",
                    "affiliation": "Children's Hospital of Philadelphia",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Megan Atkinson",
                            "role": "CONTACT",
                            "phone": "215-590-2820",
                            "email": "cttsbmtintake@chop.edu"
                        },
                        {
                            "name": "Patricia Hankins, BSN, RN, CCRC",
                            "role": "CONTACT",
                            "phone": "215-590-5168",
                            "email": "hankinsp@chop.edu"
                        },
                        {
                            "name": "Timothy Olson, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Stephan A Grupp, MD, PhD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34872106",
                    "type": "DERIVED",
                    "citation": "Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N. Unrelated donor alpha/beta T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia. Blood Adv. 2022 Feb 22;6(4):1175-1185. doi: 10.1182/bloodadvances.2021005492."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019337",
                    "term": "Hematologic Neoplasms"
                },
                {
                    "id": "D000011289",
                    "term": "Preleukemia"
                },
                {
                    "id": "D000009190",
                    "term": "Myelodysplastic Syndromes"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000011230",
                    "term": "Precancerous Conditions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "asFound": "Hematologic Malignancies",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "asFound": "Myelodysplasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14111",
                    "name": "Precancerous Conditions",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplasia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "relevance": "LOW"
                },
                {
                    "id": "M5336",
                    "name": "Busulfan",
                    "relevance": "LOW"
                },
                {
                    "id": "M16615",
                    "name": "Thiotepa",
                    "relevance": "LOW"
                },
                {
                    "id": "M4279",
                    "name": "Antilymphocyte Serum",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}